Laurion Capital Management’s Avanos Medical AVNS Stock Holding History

Laurion Capital Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,948	Closed	-$311K	–	849
2018 Q4	$311K	Buy	6,948 +3,315	+91%	+$174K	0.01%	812
2018 Q3	$249K	Buy	+3,633	New	+$234K	﹤0.01%	983
2018 Q2	–	Sell	-61,470	Closed	-$2.83M	–	1322
2018 Q1	$2.83M	Buy	61,470 +41,115	+202%	+$1.95M	0.02%	534
2017 Q4	$940K	Buy	+20,355	New	+$936K	﹤0.01%	984
2017 Q3	–	Sell	-28,600	Closed	-$1.12M	–	1539
2017 Q2	$1.12M	Buy	+28,600	New	+$1.08M	0.01%	985
2015 Q1	–	Sell	-279,042	Closed	-$12.7M	–	333
2014 Q4	$12.7M	Buy	+279,042	New	+$11M	0.29%	59

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Laurion Capital Management's AVNS Position: Q1 2019 in Review

Laurion Capital Management sold out of Avanos Medical (AVNS) in Q1 2019, closing a stake of 6,948 shares — an estimated $311K sold.

Laurion Capital Management first reported a position in AVNS in Q4 2014 and held it in 6 quarters. The position peaked at $12.7M in Q4 2014. 338 funds tracked by Wall St. Rank hold AVNS as of Q1 2019.

Laurion Capital Management reported no remaining Avanos Medical position as of Q1 2019 after selling out during the quarter.
Laurion Capital Management sold 6,948 Avanos Medical shares in Q1 2019, an estimated $311K.
Laurion Capital Management first reported a position in Avanos Medical in Q4 2014 and held it in 6 quarters.
Laurion Capital Management's Avanos Medical position peaked at $12.7M in Q4 2014.
338 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2019.

Based on Laurion Capital Management's 13F filing for Q1 2019, filed 8 May 2019.